Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Metapneumovirus”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Not applicableStudy completedNCT03574532
What this trial is testing

Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human Metapneumovirus and Influenza A Infected Hospitalized Participants (Adults and Children)

Who this might be right for
Respiratory Tract Infections
Janssen-Cilag International NV 118
Testing effectiveness (Phase 2)WithdrawnNCT03502694
What this trial is testing

Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus

Who this might be right for
Metapneumovirus
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Active Not RecruitingNCT06686654
What this trial is testing

Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older

Who this might be right for
Human Metapneumovirus ImmunizationRespiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 1,530
Not applicableStudy completedNCT02984280
What this trial is testing

Specific Respiratory Infections as Triggers of Acute Medical Events

Who this might be right for
Influenza, HumanRespiratory Syncytial Virus InfectionsParainfluenza+4 more
University College, London 787,000
Not applicableStudy completedNCT01302418
What this trial is testing

Collection and Testing of Respiratory Samples

Who this might be right for
QIAGEN ResPlex II Advanced PanelInfluenza ARespiratory Syncytial Virus Infections+15 more
QIAGEN Gaithersburg, Inc 272
Testing effectiveness (Phase 2)Study completedNCT06481579
What this trial is testing

IVX-A12 in Adults Participants

Who this might be right for
Healthy Participants
Icosavax, Inc. 143
Not applicableUnknownNCT00613184
What this trial is testing

Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses

Who this might be right for
Respiratory Syncytial VirusHuman MetapneumovirusInfluenza+2 more
Kern Medical Center 150
Early research (Phase 1)Active Not RecruitingNCT05743881
What this trial is testing

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

Who this might be right for
Respiratory Syncytial VirusHuman Metapneumovirus
ModernaTX, Inc. 186
Not applicableLooking for participantsNCT05864118
What this trial is testing

Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses

Who this might be right for
Respiratory Tract Infections
University of Nebraska 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06665100
What this trial is testing

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Who this might be right for
Hematologic MalignanciesHematopoietic Stem Cell Transplant (HSCT)
Pulmotect, Inc. 100
Early research (Phase 1)Study completedNCT06850051
What this trial is testing

A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.

Who this might be right for
Healthy VolunteersInfluenza VaccinationRespiratory Syncytial Virus Vaccination+2 more
Sanofi 270
Early research (Phase 1)Study completedNCT06583031
What this trial is testing

Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years

Who this might be right for
RSV InfectionhMPV
Sanofi Pasteur, a Sanofi Company 385
Early research (Phase 1)Study completedNCT01255410
What this trial is testing

Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine

Who this might be right for
Metapneumovirus
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT05664334
What this trial is testing

Safety and Immunogenicity of IVX-A12 in Healthy Older Adults

Who this might be right for
Healthy
Icosavax, Inc. 140
Early research (Phase 1)Study completedNCT01109329
What this trial is testing

Safety Study of a Human Metapneumovirus Challenge Virus in Healthy Adults

Who this might be right for
Human Metapneumovirus
National Institute of Allergy and Infectious Diseases (NIAID) 21
Early research (Phase 1)Looking for participantsNCT06984094
What this trial is testing

First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

Who this might be right for
Respiratory Syncytial Virus VaccinationHuman Metapneumovirus VaccinationParainfluenza Vaccination
Clover Biopharmaceuticals AUS Pty 192
Early research (Phase 1)Active Not RecruitingNCT06556147
What this trial is testing

RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults

Who this might be right for
Healthy Volunteers
Vicebio Australia Proprietary Limited 144
Testing effectiveness (Phase 2)Ended earlyNCT04933968
What this trial is testing

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Who this might be right for
Respiratory Tract Viral InfectionsHuman Metapneumovirus (hMPV) InfectionParainfluenza (PIV) Infection+2 more
AlloVir 17
Not applicableStudy completedNCT06309212
What this trial is testing

Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults

Who this might be right for
The Prevalance of HMPV After COVID-19 PandemicThe Importance of Accurate Diagnosis for HPMV
Acibadem University 2,197
Not applicableEnded earlyNCT04431050
What this trial is testing

Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens

Who this might be right for
Human InfluenzaRespiratory Syncytial Virus InfectionsRhinoviral Infections+3 more
Imperial College London 6
Load More Results